Metformin, Exenatide, and Glargine Insulin in Combination for Treatment of Patients With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 05 Feb 2013
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms MEXELIN
- 31 Aug 2018 Biomarkers information updated
- 03 May 2012 Actual patient number added 40 according to ClinicalTrials.gov.
- 12 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.